Skip to content
Screener

West Pharmaceutical Services WST Interest Income

Interest Income at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4M-20.0%
AptarGroup logo
AptarGroupATR
$3.64M+29.4%
Dow logo
DowDOW
$38M-2.6%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$60.88K-52.2%
Sonoco Products logo
Sonoco ProductsSON
$4.06M-1.4%
Amcor logo
AmcorAMCR
$17M+70.0%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.7B+44.8%
Enterprise value$24.58B+45.8%
P/E43.7×+8.7×
P/S7.4×+1.7×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other expense (income) (Note 14)12.85.216.825.8
Operating profit179.1153.7356.2260.7
Interest expense, net2.60.14.50.5
Interest income(3.8)(3.6)(8.9)(7.7)
Other nonoperating expense (income)0.20.20.40.4
Income before income taxes and equity in net income of affiliated companies180.1157.0360.2267.5
Income tax expense32.230.276.954.3
Equity in net income of affiliated companies(6.1)(5.0)(9.5)(8.4)

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's interest income?
West Pharmaceutical Services (WST) reported interest income of $3.8M in Q2 2026.
How has West Pharmaceutical Services's interest income changed year-over-year?
West Pharmaceutical Services's interest income increased by 5.6% year-over-year, from $3.6M to $3.8M.
What is the long-term trend for West Pharmaceutical Services's interest income?
Over 4 years (2021 to 2025), West Pharmaceutical Services's interest income has grown at a 104.5% compound annual growth rate (CAGR), from $1M to $17.5M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about West Pharmaceutical Services's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude